This is a Validated Antibody Database (VAD) review about human STX4, based on 4 published articles (read how Labome selects the articles), using STX4 antibody in all methods. It is aimed to help Labome visitors find the most suited STX4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
STX4 synonym: STX4A; p35-2; syntaxin-4; renal carcinoma antigen NY-REN-31; syntaxin 4A (placental)
Santa Cruz Biotechnology
mouse monoclonal (QQ-17) |
| Santa Cruz Biotechnology STX4 antibody (Santa Cruz, SC-101301) was used in immunohistochemistry on human samples (fig 4). Mol Vis (2016) ncbi |
mouse monoclonal (QQ-17) |
| In order to analyze myogenic differentiation promotion by syntaxin 4 regulation on the surface localization of Cdo, a promyogenic receptor, Santa Cruz Biotechnology STX4 antibody (Santa Cruz Biotechnology, sc-101301) was used in western blot on mouse samples (fig 2). Skelet Muscle (2015) ncbi |
BD Biosciences
mouse monoclonal (49/Syntaxin 4) |
| BD Biosciences STX4 antibody (BD Biosciences, 610439) was used in immunoprecipitation on human samples (fig 4a). J Biol Chem (2017) ncbi |
mouse monoclonal (49/Syntaxin 4) |
| In order to study the trafficking of MT1-MMP to invadopodia during tumor invasion and the roles played by SNAP23, syntaxin-4 and VAMP7, BD Biosciences STX4 antibody (BD Biosciences, 610439) was used in immunoprecipitation on human samples and in immunocytochemistry on human samples . Mol Biol Cell (2014) ncbi |
Articles Reviewed
- Kochounian H, Zhang Z, Spee C, Hinton D, Fong H. Targeting of exon VI-skipping human RGR-opsin to the plasma membrane of pigment epithelium and co-localization with terminal complement complex C5b-9. Mol Vis. 2016;22:213-23 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments